Form 8-K - Current report:
SEC Accession No. 0001104659-25-066986
Filing Date
2025-07-10
Accepted
2025-07-10 16:06:59
Documents
13
Period of Report
2025-07-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520217d1_8k.htm   iXBRL 8-K 33011
2 EXHIBIT 16.1 tm2520217d1_ex16-1.htm EX-16.1 2455
  Complete submission text file 0001104659-25-066986.txt   203723

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20250703.xsd EX-101.SCH 3032
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20250703_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20250703_pre.xml EX-101.PRE 22370
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2520217d1_8k_htm.xml XML 3686
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 251116413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)